nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—Buclizine—Imatinib—hematologic cancer	0.236	0.524	CrCrCtD
Cyclizine—Meclizine—Imatinib—hematologic cancer	0.215	0.476	CrCrCtD
Cyclizine—CYP2C9—Bexarotene—hematologic cancer	0.0508	0.191	CbGbCtD
Cyclizine—CYP2C9—Idarubicin—hematologic cancer	0.0421	0.159	CbGbCtD
Cyclizine—CYP2C9—Bortezomib—hematologic cancer	0.0311	0.117	CbGbCtD
Cyclizine—CYP2C9—Thalidomide—hematologic cancer	0.0271	0.102	CbGbCtD
Cyclizine—CYP2C9—Teniposide—hematologic cancer	0.0259	0.0975	CbGbCtD
Cyclizine—CYP2C9—Ifosfamide—hematologic cancer	0.0239	0.09	CbGbCtD
Cyclizine—CYP2C9—Imatinib—hematologic cancer	0.0228	0.0859	CbGbCtD
Cyclizine—CYP2C9—Nilotinib—hematologic cancer	0.0207	0.0781	CbGbCtD
Cyclizine—CYP2C9—Cisplatin—hematologic cancer	0.0116	0.0438	CbGbCtD
Cyclizine—CYP2C9—Dexamethasone—hematologic cancer	0.00938	0.0353	CbGbCtD
Cyclizine—SULT1E1—hematopoietic system—hematologic cancer	0.00758	0.248	CbGeAlD
Cyclizine—SULT1E1—gonad—hematologic cancer	0.00576	0.188	CbGeAlD
Cyclizine—SULT1E1—lung—hematologic cancer	0.0044	0.144	CbGeAlD
Cyclizine—SULT1E1—testis—hematologic cancer	0.00415	0.136	CbGeAlD
Cyclizine—SULT1E1—lymph node—hematologic cancer	0.00301	0.0983	CbGeAlD
Cyclizine—CYP2C9—hematopoietic system—hematologic cancer	0.00137	0.0449	CbGeAlD
Cyclizine—HRH1—hematopoietic system—hematologic cancer	0.00135	0.0443	CbGeAlD
Cyclizine—CYP2C9—blood—hematologic cancer	0.00091	0.0297	CbGeAlD
Cyclizine—HRH1—lung—hematologic cancer	0.000787	0.0257	CbGeAlD
Cyclizine—HRH1—testis—hematologic cancer	0.000742	0.0243	CbGeAlD
Cyclizine—HRH1—lymph node—hematologic cancer	0.000538	0.0176	CbGeAlD
Cyclizine—Clozapine—H1F0—hematologic cancer	0.000178	0.322	CrCbGaD
Cyclizine—Skin disorder—Cisplatin—hematologic cancer	0.000106	0.000519	CcSEcCtD
Cyclizine—Insomnia—Gemcitabine—hematologic cancer	0.000106	0.000518	CcSEcCtD
Cyclizine—Hypertension—Etoposide—hematologic cancer	0.000106	0.000518	CcSEcCtD
Cyclizine—Dizziness—Hydroxyurea—hematologic cancer	0.000106	0.000518	CcSEcCtD
Cyclizine—Pruritus—Bortezomib—hematologic cancer	0.000106	0.000517	CcSEcCtD
Cyclizine—Pain—Vincristine—hematologic cancer	0.000106	0.000517	CcSEcCtD
Cyclizine—Constipation—Vincristine—hematologic cancer	0.000106	0.000517	CcSEcCtD
Cyclizine—Paraesthesia—Gemcitabine—hematologic cancer	0.000105	0.000515	CcSEcCtD
Cyclizine—Pruritus—Bleomycin—hematologic cancer	0.000105	0.000513	CcSEcCtD
Cyclizine—Convulsion—Prednisolone—hematologic cancer	0.000105	0.000513	CcSEcCtD
Cyclizine—Asthenia—Vinorelbine—hematologic cancer	0.000105	0.000512	CcSEcCtD
Cyclizine—Hypertension—Prednisolone—hematologic cancer	0.000104	0.000511	CcSEcCtD
Cyclizine—Somnolence—Gemcitabine—hematologic cancer	0.000104	0.00051	CcSEcCtD
Cyclizine—Pruritus—Vinorelbine—hematologic cancer	0.000103	0.000505	CcSEcCtD
Cyclizine—Pain—Irinotecan—hematologic cancer	0.000103	0.000503	CcSEcCtD
Cyclizine—Constipation—Irinotecan—hematologic cancer	0.000103	0.000503	CcSEcCtD
Cyclizine—Constipation—Mitoxantrone—hematologic cancer	0.000103	0.000503	CcSEcCtD
Cyclizine—Pain—Mitoxantrone—hematologic cancer	0.000103	0.000503	CcSEcCtD
Cyclizine—Hypersensitivity—Thiotepa—hematologic cancer	0.000103	0.000502	CcSEcCtD
Cyclizine—Hypotension—Cisplatin—hematologic cancer	0.000102	0.000499	CcSEcCtD
Cyclizine—Urticaria—Alitretinoin—hematologic cancer	0.000102	0.000498	CcSEcCtD
Cyclizine—Headache—Lenalidomide—hematologic cancer	0.000102	0.000497	CcSEcCtD
Cyclizine—Angioedema—Triamcinolone—hematologic cancer	0.000102	0.000497	CcSEcCtD
Cyclizine—Erythema—Betamethasone—hematologic cancer	0.000101	0.000494	CcSEcCtD
Cyclizine—Erythema—Dexamethasone—hematologic cancer	0.000101	0.000494	CcSEcCtD
Cyclizine—Urticaria—Ifosfamide—hematologic cancer	0.000101	0.000492	CcSEcCtD
Cyclizine—Headache—Hydroxyurea—hematologic cancer	0.0001	0.000491	CcSEcCtD
Cyclizine—Pain—Gemcitabine—hematologic cancer	0.0001	0.00049	CcSEcCtD
Cyclizine—Constipation—Gemcitabine—hematologic cancer	0.0001	0.00049	CcSEcCtD
Cyclizine—Anaphylactic shock—Etoposide—hematologic cancer	0.0001	0.000489	CcSEcCtD
Cyclizine—Asthenia—Thiotepa—hematologic cancer	9.99e-05	0.000489	CcSEcCtD
Cyclizine—Hypersensitivity—Thalidomide—hematologic cancer	9.93e-05	0.000486	CcSEcCtD
Cyclizine—Connective tissue disorder—Prednisone—hematologic cancer	9.92e-05	0.000485	CcSEcCtD
Cyclizine—Dizziness—Bortezomib—hematologic cancer	9.88e-05	0.000483	CcSEcCtD
Cyclizine—Anaphylactic shock—Prednisolone—hematologic cancer	9.87e-05	0.000483	CcSEcCtD
Cyclizine—Pruritus—Thiotepa—hematologic cancer	9.85e-05	0.000482	CcSEcCtD
Cyclizine—Paraesthesia—Cisplatin—hematologic cancer	9.81e-05	0.00048	CcSEcCtD
Cyclizine—Tachycardia—Etoposide—hematologic cancer	9.77e-05	0.000478	CcSEcCtD
Cyclizine—Skin disorder—Etoposide—hematologic cancer	9.72e-05	0.000475	CcSEcCtD
Cyclizine—Asthenia—Thalidomide—hematologic cancer	9.67e-05	0.000473	CcSEcCtD
Cyclizine—Dizziness—Vinorelbine—hematologic cancer	9.64e-05	0.000472	CcSEcCtD
Cyclizine—Convulsion—Triamcinolone—hematologic cancer	9.63e-05	0.000471	CcSEcCtD
Cyclizine—Tachycardia—Prednisolone—hematologic cancer	9.63e-05	0.000471	CcSEcCtD
Cyclizine—Hypertension—Triamcinolone—hematologic cancer	9.6e-05	0.00047	CcSEcCtD
Cyclizine—Urticaria—Mitoxantrone—hematologic cancer	9.56e-05	0.000467	CcSEcCtD
Cyclizine—Hypersensitivity—Carmustine—hematologic cancer	9.53e-05	0.000466	CcSEcCtD
Cyclizine—Pruritus—Thalidomide—hematologic cancer	9.53e-05	0.000466	CcSEcCtD
Cyclizine—Hypersensitivity—Alitretinoin—hematologic cancer	9.44e-05	0.000462	CcSEcCtD
Cyclizine—Eye disorder—Prednisone—hematologic cancer	9.43e-05	0.000461	CcSEcCtD
Cyclizine—Drowsiness—Methotrexate—hematologic cancer	9.4e-05	0.00046	CcSEcCtD
Cyclizine—Phenoxybenzamine—SLC22A1—hematologic cancer	9.37e-05	0.169	CrCbGaD
Cyclizine—Headache—Bortezomib—hematologic cancer	9.36e-05	0.000458	CcSEcCtD
Cyclizine—Hypotension—Etoposide—hematologic cancer	9.35e-05	0.000457	CcSEcCtD
Cyclizine—Pain—Cisplatin—hematologic cancer	9.34e-05	0.000457	CcSEcCtD
Cyclizine—Hypersensitivity—Ifosfamide—hematologic cancer	9.33e-05	0.000457	CcSEcCtD
Cyclizine—Asthenia—Carmustine—hematologic cancer	9.28e-05	0.000454	CcSEcCtD
Cyclizine—Angioedema—Betamethasone—hematologic cancer	9.22e-05	0.000451	CcSEcCtD
Cyclizine—Angioedema—Dexamethasone—hematologic cancer	9.22e-05	0.000451	CcSEcCtD
Cyclizine—Dizziness—Thiotepa—hematologic cancer	9.21e-05	0.000451	CcSEcCtD
Cyclizine—Asthenia—Alitretinoin—hematologic cancer	9.2e-05	0.00045	CcSEcCtD
Cyclizine—Headache—Vinorelbine—hematologic cancer	9.14e-05	0.000447	CcSEcCtD
Cyclizine—Hypersensitivity—Vincristine—hematologic cancer	9.1e-05	0.000445	CcSEcCtD
Cyclizine—Asthenia—Ifosfamide—hematologic cancer	9.09e-05	0.000445	CcSEcCtD
Cyclizine—Anaphylactic shock—Triamcinolone—hematologic cancer	9.08e-05	0.000444	CcSEcCtD
Cyclizine—Pruritus—Alitretinoin—hematologic cancer	9.07e-05	0.000444	CcSEcCtD
Cyclizine—Paraesthesia—Etoposide—hematologic cancer	8.98e-05	0.00044	CcSEcCtD
Cyclizine—Pruritus—Ifosfamide—hematologic cancer	8.96e-05	0.000438	CcSEcCtD
Cyclizine—Insomnia—Prednisolone—hematologic cancer	8.93e-05	0.000437	CcSEcCtD
Cyclizine—Dizziness—Thalidomide—hematologic cancer	8.91e-05	0.000436	CcSEcCtD
Cyclizine—Somnolence—Etoposide—hematologic cancer	8.89e-05	0.000435	CcSEcCtD
Cyclizine—Hepatobiliary disease—Methotrexate—hematologic cancer	8.89e-05	0.000435	CcSEcCtD
Cyclizine—Hypersensitivity—Mitoxantrone—hematologic cancer	8.86e-05	0.000434	CcSEcCtD
Cyclizine—Hypersensitivity—Irinotecan—hematologic cancer	8.86e-05	0.000434	CcSEcCtD
Cyclizine—Asthenia—Vincristine—hematologic cancer	8.86e-05	0.000434	CcSEcCtD
Cyclizine—Paraesthesia—Prednisolone—hematologic cancer	8.86e-05	0.000434	CcSEcCtD
Cyclizine—Tachycardia—Triamcinolone—hematologic cancer	8.86e-05	0.000433	CcSEcCtD
Cyclizine—Mental disorder—Prednisone—hematologic cancer	8.84e-05	0.000433	CcSEcCtD
Cyclizine—Drowsiness—Epirubicin—hematologic cancer	8.79e-05	0.00043	CcSEcCtD
Cyclizine—Erythema—Prednisone—hematologic cancer	8.79e-05	0.00043	CcSEcCtD
Cyclizine—Agranulocytosis—Methotrexate—hematologic cancer	8.77e-05	0.000429	CcSEcCtD
Cyclizine—Convulsion—Betamethasone—hematologic cancer	8.74e-05	0.000428	CcSEcCtD
Cyclizine—Convulsion—Dexamethasone—hematologic cancer	8.74e-05	0.000428	CcSEcCtD
Cyclizine—Headache—Thiotepa—hematologic cancer	8.73e-05	0.000427	CcSEcCtD
Cyclizine—Hypertension—Betamethasone—hematologic cancer	8.71e-05	0.000426	CcSEcCtD
Cyclizine—Hypertension—Dexamethasone—hematologic cancer	8.71e-05	0.000426	CcSEcCtD
Cyclizine—Asthenia—Irinotecan—hematologic cancer	8.63e-05	0.000422	CcSEcCtD
Cyclizine—Asthenia—Mitoxantrone—hematologic cancer	8.63e-05	0.000422	CcSEcCtD
Cyclizine—Dizziness—Carmustine—hematologic cancer	8.56e-05	0.000419	CcSEcCtD
Cyclizine—Pain—Etoposide—hematologic cancer	8.56e-05	0.000419	CcSEcCtD
Cyclizine—Constipation—Etoposide—hematologic cancer	8.56e-05	0.000419	CcSEcCtD
Cyclizine—Dizziness—Alitretinoin—hematologic cancer	8.48e-05	0.000415	CcSEcCtD
Cyclizine—Headache—Thalidomide—hematologic cancer	8.44e-05	0.000413	CcSEcCtD
Cyclizine—Pain—Prednisolone—hematologic cancer	8.44e-05	0.000413	CcSEcCtD
Cyclizine—Hepatitis—Methotrexate—hematologic cancer	8.44e-05	0.000413	CcSEcCtD
Cyclizine—Asthenia—Gemcitabine—hematologic cancer	8.41e-05	0.000411	CcSEcCtD
Cyclizine—Dizziness—Ifosfamide—hematologic cancer	8.38e-05	0.00041	CcSEcCtD
Cyclizine—Hepatobiliary disease—Epirubicin—hematologic cancer	8.32e-05	0.000407	CcSEcCtD
Cyclizine—Pruritus—Gemcitabine—hematologic cancer	8.29e-05	0.000406	CcSEcCtD
Cyclizine—Vision blurred—Prednisone—hematologic cancer	8.28e-05	0.000405	CcSEcCtD
Cyclizine—Anaphylactic shock—Dexamethasone—hematologic cancer	8.23e-05	0.000403	CcSEcCtD
Cyclizine—Anaphylactic shock—Betamethasone—hematologic cancer	8.23e-05	0.000403	CcSEcCtD
Cyclizine—Insomnia—Triamcinolone—hematologic cancer	8.21e-05	0.000402	CcSEcCtD
Cyclizine—Agranulocytosis—Epirubicin—hematologic cancer	8.21e-05	0.000401	CcSEcCtD
Cyclizine—Dizziness—Vincristine—hematologic cancer	8.17e-05	0.0004	CcSEcCtD
Cyclizine—Paraesthesia—Triamcinolone—hematologic cancer	8.15e-05	0.000399	CcSEcCtD
Cyclizine—Drowsiness—Doxorubicin—hematologic cancer	8.14e-05	0.000398	CcSEcCtD
Cyclizine—Headache—Carmustine—hematologic cancer	8.11e-05	0.000397	CcSEcCtD
Cyclizine—Nervous system disorder—Betamethasone—hematologic cancer	8.08e-05	0.000395	CcSEcCtD
Cyclizine—Nervous system disorder—Dexamethasone—hematologic cancer	8.08e-05	0.000395	CcSEcCtD
Cyclizine—Agitation—Prednisone—hematologic cancer	8.07e-05	0.000395	CcSEcCtD
Cyclizine—Hypersensitivity—Cisplatin—hematologic cancer	8.05e-05	0.000394	CcSEcCtD
Cyclizine—Tachycardia—Dexamethasone—hematologic cancer	8.04e-05	0.000393	CcSEcCtD
Cyclizine—Tachycardia—Betamethasone—hematologic cancer	8.04e-05	0.000393	CcSEcCtD
Cyclizine—Headache—Alitretinoin—hematologic cancer	8.03e-05	0.000393	CcSEcCtD
Cyclizine—Angioedema—Prednisone—hematologic cancer	8.03e-05	0.000393	CcSEcCtD
Cyclizine—Dizziness—Irinotecan—hematologic cancer	7.95e-05	0.000389	CcSEcCtD
Cyclizine—Urticaria—Etoposide—hematologic cancer	7.95e-05	0.000389	CcSEcCtD
Cyclizine—Hepatitis—Epirubicin—hematologic cancer	7.89e-05	0.000386	CcSEcCtD
Cyclizine—Eye disorder—Methotrexate—hematologic cancer	7.88e-05	0.000386	CcSEcCtD
Cyclizine—Diphenhydramine—SLC22A1—hematologic cancer	7.86e-05	0.142	CrCbGaD
Cyclizine—Urticaria—Prednisolone—hematologic cancer	7.84e-05	0.000384	CcSEcCtD
Cyclizine—Asthenia—Cisplatin—hematologic cancer	7.84e-05	0.000383	CcSEcCtD
Cyclizine—Pain—Triamcinolone—hematologic cancer	7.76e-05	0.00038	CcSEcCtD
Cyclizine—Connective tissue disorder—Epirubicin—hematologic cancer	7.76e-05	0.00038	CcSEcCtD
Cyclizine—Headache—Vincristine—hematologic cancer	7.74e-05	0.000379	CcSEcCtD
Cyclizine—Hepatobiliary disease—Doxorubicin—hematologic cancer	7.7e-05	0.000376	CcSEcCtD
Cyclizine—Hypotension—Betamethasone—hematologic cancer	7.69e-05	0.000376	CcSEcCtD
Cyclizine—Hypotension—Dexamethasone—hematologic cancer	7.69e-05	0.000376	CcSEcCtD
Cyclizine—Convulsion—Prednisone—hematologic cancer	7.61e-05	0.000372	CcSEcCtD
Cyclizine—Agranulocytosis—Doxorubicin—hematologic cancer	7.59e-05	0.000371	CcSEcCtD
Cyclizine—Hypertension—Prednisone—hematologic cancer	7.59e-05	0.000371	CcSEcCtD
Cyclizine—Chills—Methotrexate—hematologic cancer	7.57e-05	0.00037	CcSEcCtD
Cyclizine—Headache—Mitoxantrone—hematologic cancer	7.54e-05	0.000369	CcSEcCtD
Cyclizine—Headache—Irinotecan—hematologic cancer	7.54e-05	0.000369	CcSEcCtD
Cyclizine—Insomnia—Betamethasone—hematologic cancer	7.45e-05	0.000364	CcSEcCtD
Cyclizine—Insomnia—Dexamethasone—hematologic cancer	7.45e-05	0.000364	CcSEcCtD
Cyclizine—Paraesthesia—Betamethasone—hematologic cancer	7.39e-05	0.000362	CcSEcCtD
Cyclizine—Paraesthesia—Dexamethasone—hematologic cancer	7.39e-05	0.000362	CcSEcCtD
Cyclizine—Mental disorder—Methotrexate—hematologic cancer	7.39e-05	0.000362	CcSEcCtD
Cyclizine—Eye disorder—Epirubicin—hematologic cancer	7.38e-05	0.000361	CcSEcCtD
Cyclizine—Hypersensitivity—Etoposide—hematologic cancer	7.37e-05	0.000361	CcSEcCtD
Cyclizine—Erythema—Methotrexate—hematologic cancer	7.34e-05	0.000359	CcSEcCtD
Cyclizine—Headache—Gemcitabine—hematologic cancer	7.34e-05	0.000359	CcSEcCtD
Cyclizine—Hepatitis—Doxorubicin—hematologic cancer	7.3e-05	0.000357	CcSEcCtD
Cyclizine—Hypersensitivity—Prednisolone—hematologic cancer	7.27e-05	0.000356	CcSEcCtD
Cyclizine—Urticaria—Triamcinolone—hematologic cancer	7.21e-05	0.000353	CcSEcCtD
Cyclizine—Asthenia—Etoposide—hematologic cancer	7.18e-05	0.000351	CcSEcCtD
Cyclizine—Connective tissue disorder—Doxorubicin—hematologic cancer	7.18e-05	0.000351	CcSEcCtD
Cyclizine—Anaphylactic shock—Prednisone—hematologic cancer	7.17e-05	0.000351	CcSEcCtD
Cyclizine—Chills—Epirubicin—hematologic cancer	7.08e-05	0.000347	CcSEcCtD
Cyclizine—Pruritus—Etoposide—hematologic cancer	7.08e-05	0.000346	CcSEcCtD
Cyclizine—Pain—Dexamethasone—hematologic cancer	7.04e-05	0.000344	CcSEcCtD
Cyclizine—Pain—Betamethasone—hematologic cancer	7.04e-05	0.000344	CcSEcCtD
Cyclizine—Nervous system disorder—Prednisone—hematologic cancer	7.03e-05	0.000344	CcSEcCtD
Cyclizine—Reboxetine—ABCB1—hematologic cancer	7.02e-05	0.127	CrCbGaD
Cyclizine—Tachycardia—Prednisone—hematologic cancer	7e-05	0.000342	CcSEcCtD
Cyclizine—Skin disorder—Prednisone—hematologic cancer	6.97e-05	0.000341	CcSEcCtD
Cyclizine—Vision blurred—Methotrexate—hematologic cancer	6.92e-05	0.000339	CcSEcCtD
Cyclizine—Mental disorder—Epirubicin—hematologic cancer	6.92e-05	0.000338	CcSEcCtD
Cyclizine—Erythema—Epirubicin—hematologic cancer	6.87e-05	0.000336	CcSEcCtD
Cyclizine—Eye disorder—Doxorubicin—hematologic cancer	6.83e-05	0.000334	CcSEcCtD
Cyclizine—Tension—Epirubicin—hematologic cancer	6.74e-05	0.00033	CcSEcCtD
Cyclizine—Hypersensitivity—Triamcinolone—hematologic cancer	6.69e-05	0.000327	CcSEcCtD
Cyclizine—Nervousness—Epirubicin—hematologic cancer	6.67e-05	0.000327	CcSEcCtD
Cyclizine—Dizziness—Etoposide—hematologic cancer	6.62e-05	0.000324	CcSEcCtD
Cyclizine—Muscle spasms—Epirubicin—hematologic cancer	6.61e-05	0.000323	CcSEcCtD
Cyclizine—Chills—Doxorubicin—hematologic cancer	6.55e-05	0.000321	CcSEcCtD
Cyclizine—Urticaria—Dexamethasone—hematologic cancer	6.54e-05	0.00032	CcSEcCtD
Cyclizine—Urticaria—Betamethasone—hematologic cancer	6.54e-05	0.00032	CcSEcCtD
Cyclizine—Dizziness—Prednisolone—hematologic cancer	6.53e-05	0.000319	CcSEcCtD
Cyclizine—Asthenia—Triamcinolone—hematologic cancer	6.51e-05	0.000319	CcSEcCtD
Cyclizine—Insomnia—Prednisone—hematologic cancer	6.49e-05	0.000317	CcSEcCtD
Cyclizine—Vision blurred—Epirubicin—hematologic cancer	6.48e-05	0.000317	CcSEcCtD
Cyclizine—Paraesthesia—Prednisone—hematologic cancer	6.44e-05	0.000315	CcSEcCtD
Cyclizine—Pruritus—Triamcinolone—hematologic cancer	6.42e-05	0.000314	CcSEcCtD
Cyclizine—Mental disorder—Doxorubicin—hematologic cancer	6.4e-05	0.000313	CcSEcCtD
Cyclizine—Convulsion—Methotrexate—hematologic cancer	6.36e-05	0.000311	CcSEcCtD
Cyclizine—Erythema—Doxorubicin—hematologic cancer	6.36e-05	0.000311	CcSEcCtD
Cyclizine—Agitation—Epirubicin—hematologic cancer	6.32e-05	0.000309	CcSEcCtD
Cyclizine—Headache—Etoposide—hematologic cancer	6.27e-05	0.000307	CcSEcCtD
Cyclizine—Tension—Doxorubicin—hematologic cancer	6.24e-05	0.000305	CcSEcCtD
Cyclizine—Headache—Prednisolone—hematologic cancer	6.18e-05	0.000302	CcSEcCtD
Cyclizine—Nervousness—Doxorubicin—hematologic cancer	6.18e-05	0.000302	CcSEcCtD
Cyclizine—Constipation—Prednisone—hematologic cancer	6.13e-05	0.0003	CcSEcCtD
Cyclizine—Muscle spasms—Doxorubicin—hematologic cancer	6.11e-05	0.000299	CcSEcCtD
Cyclizine—Dizziness—Triamcinolone—hematologic cancer	6e-05	0.000294	CcSEcCtD
Cyclizine—Anaphylactic shock—Methotrexate—hematologic cancer	5.99e-05	0.000293	CcSEcCtD
Cyclizine—Vision blurred—Doxorubicin—hematologic cancer	5.99e-05	0.000293	CcSEcCtD
Cyclizine—Convulsion—Epirubicin—hematologic cancer	5.95e-05	0.000291	CcSEcCtD
Cyclizine—Hypertension—Epirubicin—hematologic cancer	5.93e-05	0.00029	CcSEcCtD
Cyclizine—Asthenia—Betamethasone—hematologic cancer	5.91e-05	0.000289	CcSEcCtD
Cyclizine—Asthenia—Dexamethasone—hematologic cancer	5.91e-05	0.000289	CcSEcCtD
Cyclizine—Nervous system disorder—Methotrexate—hematologic cancer	5.88e-05	0.000288	CcSEcCtD
Cyclizine—Agitation—Doxorubicin—hematologic cancer	5.84e-05	0.000286	CcSEcCtD
Cyclizine—Pruritus—Betamethasone—hematologic cancer	5.83e-05	0.000285	CcSEcCtD
Cyclizine—Pruritus—Dexamethasone—hematologic cancer	5.83e-05	0.000285	CcSEcCtD
Cyclizine—Skin disorder—Methotrexate—hematologic cancer	5.82e-05	0.000285	CcSEcCtD
Cyclizine—Urticaria—Prednisone—hematologic cancer	5.7e-05	0.000279	CcSEcCtD
Cyclizine—Headache—Triamcinolone—hematologic cancer	5.69e-05	0.000278	CcSEcCtD
Cyclizine—Anaphylactic shock—Epirubicin—hematologic cancer	5.61e-05	0.000274	CcSEcCtD
Cyclizine—Hypotension—Methotrexate—hematologic cancer	5.6e-05	0.000274	CcSEcCtD
Cyclizine—Convulsion—Doxorubicin—hematologic cancer	5.51e-05	0.00027	CcSEcCtD
Cyclizine—Nervous system disorder—Epirubicin—hematologic cancer	5.5e-05	0.000269	CcSEcCtD
Cyclizine—Hypertension—Doxorubicin—hematologic cancer	5.49e-05	0.000269	CcSEcCtD
Cyclizine—Tachycardia—Epirubicin—hematologic cancer	5.47e-05	0.000268	CcSEcCtD
Cyclizine—Skin disorder—Epirubicin—hematologic cancer	5.45e-05	0.000267	CcSEcCtD
Cyclizine—Dizziness—Betamethasone—hematologic cancer	5.45e-05	0.000266	CcSEcCtD
Cyclizine—Dizziness—Dexamethasone—hematologic cancer	5.45e-05	0.000266	CcSEcCtD
Cyclizine—Insomnia—Methotrexate—hematologic cancer	5.42e-05	0.000265	CcSEcCtD
Cyclizine—Paraesthesia—Methotrexate—hematologic cancer	5.38e-05	0.000263	CcSEcCtD
Cyclizine—Somnolence—Methotrexate—hematologic cancer	5.33e-05	0.000261	CcSEcCtD
Cyclizine—Hypersensitivity—Prednisone—hematologic cancer	5.28e-05	0.000258	CcSEcCtD
Cyclizine—Hypotension—Epirubicin—hematologic cancer	5.24e-05	0.000256	CcSEcCtD
Cyclizine—Anaphylactic shock—Doxorubicin—hematologic cancer	5.19e-05	0.000254	CcSEcCtD
Cyclizine—Headache—Dexamethasone—hematologic cancer	5.16e-05	0.000252	CcSEcCtD
Cyclizine—Headache—Betamethasone—hematologic cancer	5.16e-05	0.000252	CcSEcCtD
Cyclizine—Asthenia—Prednisone—hematologic cancer	5.15e-05	0.000252	CcSEcCtD
Cyclizine—Pain—Methotrexate—hematologic cancer	5.12e-05	0.000251	CcSEcCtD
Cyclizine—Nervous system disorder—Doxorubicin—hematologic cancer	5.09e-05	0.000249	CcSEcCtD
Cyclizine—Pruritus—Prednisone—hematologic cancer	5.07e-05	0.000248	CcSEcCtD
Cyclizine—Insomnia—Epirubicin—hematologic cancer	5.07e-05	0.000248	CcSEcCtD
Cyclizine—Tachycardia—Doxorubicin—hematologic cancer	5.06e-05	0.000248	CcSEcCtD
Cyclizine—Skin disorder—Doxorubicin—hematologic cancer	5.04e-05	0.000247	CcSEcCtD
Cyclizine—Paraesthesia—Epirubicin—hematologic cancer	5.04e-05	0.000246	CcSEcCtD
Cyclizine—Somnolence—Epirubicin—hematologic cancer	4.99e-05	0.000244	CcSEcCtD
Cyclizine—Hypotension—Doxorubicin—hematologic cancer	4.85e-05	0.000237	CcSEcCtD
Cyclizine—Constipation—Epirubicin—hematologic cancer	4.8e-05	0.000235	CcSEcCtD
Cyclizine—Pain—Epirubicin—hematologic cancer	4.8e-05	0.000235	CcSEcCtD
Cyclizine—Urticaria—Methotrexate—hematologic cancer	4.76e-05	0.000233	CcSEcCtD
Cyclizine—Dizziness—Prednisone—hematologic cancer	4.74e-05	0.000232	CcSEcCtD
Cyclizine—Phenprocoumon—ALB—hematologic cancer	4.74e-05	0.0856	CrCbGaD
Cyclizine—Insomnia—Doxorubicin—hematologic cancer	4.69e-05	0.00023	CcSEcCtD
Cyclizine—Paraesthesia—Doxorubicin—hematologic cancer	4.66e-05	0.000228	CcSEcCtD
Cyclizine—Somnolence—Doxorubicin—hematologic cancer	4.61e-05	0.000226	CcSEcCtD
Cyclizine—Headache—Prednisone—hematologic cancer	4.49e-05	0.00022	CcSEcCtD
Cyclizine—Urticaria—Epirubicin—hematologic cancer	4.46e-05	0.000218	CcSEcCtD
Cyclizine—Constipation—Doxorubicin—hematologic cancer	4.44e-05	0.000217	CcSEcCtD
Cyclizine—Pain—Doxorubicin—hematologic cancer	4.44e-05	0.000217	CcSEcCtD
Cyclizine—Hypersensitivity—Methotrexate—hematologic cancer	4.42e-05	0.000216	CcSEcCtD
Cyclizine—Asthenia—Methotrexate—hematologic cancer	4.3e-05	0.00021	CcSEcCtD
Cyclizine—Pruritus—Methotrexate—hematologic cancer	4.24e-05	0.000207	CcSEcCtD
Cyclizine—Hypersensitivity—Epirubicin—hematologic cancer	4.13e-05	0.000202	CcSEcCtD
Cyclizine—Urticaria—Doxorubicin—hematologic cancer	4.12e-05	0.000202	CcSEcCtD
Cyclizine—Asthenia—Epirubicin—hematologic cancer	4.02e-05	0.000197	CcSEcCtD
Cyclizine—Pruritus—Epirubicin—hematologic cancer	3.97e-05	0.000194	CcSEcCtD
Cyclizine—Dizziness—Methotrexate—hematologic cancer	3.96e-05	0.000194	CcSEcCtD
Cyclizine—Hypersensitivity—Doxorubicin—hematologic cancer	3.82e-05	0.000187	CcSEcCtD
Cyclizine—Headache—Methotrexate—hematologic cancer	3.75e-05	0.000184	CcSEcCtD
Cyclizine—Asthenia—Doxorubicin—hematologic cancer	3.72e-05	0.000182	CcSEcCtD
Cyclizine—Dizziness—Epirubicin—hematologic cancer	3.71e-05	0.000181	CcSEcCtD
Cyclizine—Pruritus—Doxorubicin—hematologic cancer	3.67e-05	0.00018	CcSEcCtD
Cyclizine—Headache—Epirubicin—hematologic cancer	3.51e-05	0.000172	CcSEcCtD
Cyclizine—Bepridil—ABCB1—hematologic cancer	3.5e-05	0.0631	CrCbGaD
Cyclizine—Dizziness—Doxorubicin—hematologic cancer	3.43e-05	0.000168	CcSEcCtD
Cyclizine—Headache—Doxorubicin—hematologic cancer	3.25e-05	0.000159	CcSEcCtD
Cyclizine—Fentanyl—ABCB1—hematologic cancer	3.22e-05	0.0581	CrCbGaD
Cyclizine—HRH1—Signaling by GPCR—PDE4B—hematologic cancer	2.51e-05	0.000518	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CNR2—hematologic cancer	2.51e-05	0.000518	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RAC2—hematologic cancer	2.47e-05	0.00051	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	2.46e-05	0.000508	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.41e-05	0.000497	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ARHGEF12—hematologic cancer	2.36e-05	0.000487	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADCY7—hematologic cancer	2.36e-05	0.000487	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PTHLH—hematologic cancer	2.35e-05	0.000485	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.34e-05	0.000484	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ARHGEF1—hematologic cancer	2.3e-05	0.000475	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PTGER4—hematologic cancer	2.29e-05	0.000472	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—B3GAT1—hematologic cancer	2.26e-05	0.000466	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—DCK—hematologic cancer	2.26e-05	0.000466	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ASNS—hematologic cancer	2.26e-05	0.000466	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.2e-05	0.000455	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL3—hematologic cancer	2.16e-05	0.000445	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HDC—hematologic cancer	2.14e-05	0.000441	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PTHLH—hematologic cancer	2.13e-05	0.00044	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—hematologic cancer	2.11e-05	0.000435	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PTGER4—hematologic cancer	2.08e-05	0.000429	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGRN—hematologic cancer	2.06e-05	0.000426	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL17—hematologic cancer	2.06e-05	0.000426	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCR5—hematologic cancer	2.03e-05	0.000418	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCR4—hematologic cancer	2.02e-05	0.000417	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—hematologic cancer	2.02e-05	0.000417	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.99e-05	0.000412	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEF1—hematologic cancer	1.99e-05	0.000411	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNA13—hematologic cancer	1.96e-05	0.000404	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CDA—hematologic cancer	1.96e-05	0.000404	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—IL3—hematologic cancer	1.95e-05	0.000402	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TIAM1—hematologic cancer	1.92e-05	0.000397	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—RASGRP1—hematologic cancer	1.88e-05	0.000389	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PC—hematologic cancer	1.88e-05	0.000389	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CCL2—hematologic cancer	1.87e-05	0.000387	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JAK3—hematologic cancer	1.87e-05	0.000385	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—PIK3CA—hematologic cancer	1.86e-05	0.000385	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CA—hematologic cancer	1.86e-05	0.000384	CbGpPWpGaD
Cyclizine—Clozapine—ABCB1—hematologic cancer	1.84e-05	0.0333	CrCbGaD
Cyclizine—HRH1—Signaling by GPCR—CXCR4—hematologic cancer	1.84e-05	0.000379	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GBA—hematologic cancer	1.82e-05	0.000375	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.82e-05	0.000375	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—hematologic cancer	1.81e-05	0.000374	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL13—hematologic cancer	1.79e-05	0.000369	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCR7—hematologic cancer	1.79e-05	0.000369	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL3—hematologic cancer	1.77e-05	0.000365	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NCOR2—hematologic cancer	1.77e-05	0.000365	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CRKL—hematologic cancer	1.74e-05	0.00036	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL3RA—hematologic cancer	1.74e-05	0.00036	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RASGRP1—hematologic cancer	1.71e-05	0.000353	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GRB2—hematologic cancer	1.69e-05	0.00035	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RGS2—hematologic cancer	1.68e-05	0.000347	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	1.67e-05	0.000344	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TRIO—hematologic cancer	1.66e-05	0.000343	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TRH—hematologic cancer	1.66e-05	0.000343	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CMA1—hematologic cancer	1.66e-05	0.000343	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTAP—hematologic cancer	1.66e-05	0.000343	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SPHK1—hematologic cancer	1.63e-05	0.000336	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGO2—hematologic cancer	1.63e-05	0.000336	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HDAC9—hematologic cancer	1.61e-05	0.000333	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LPAR1—hematologic cancer	1.61e-05	0.000333	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—H3F3B—hematologic cancer	1.59e-05	0.000329	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	1.54e-05	0.000318	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GRB2—hematologic cancer	1.54e-05	0.000318	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKT1—hematologic cancer	1.52e-05	0.000314	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CSF2—hematologic cancer	1.51e-05	0.000313	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CNR2—hematologic cancer	1.48e-05	0.000306	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDE4B—hematologic cancer	1.48e-05	0.000306	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—FHL2—hematologic cancer	1.48e-05	0.000306	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	1.48e-05	0.000305	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF19—hematologic cancer	1.47e-05	0.000304	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—JAK1—hematologic cancer	1.46e-05	0.000302	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCG—hematologic cancer	1.46e-05	0.000302	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RAC2—hematologic cancer	1.46e-05	0.000301	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AGRN—hematologic cancer	1.45e-05	0.0003	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DKK1—hematologic cancer	1.45e-05	0.000299	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT5B—hematologic cancer	1.44e-05	0.000296	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADCY7—hematologic cancer	1.39e-05	0.000288	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMMR—hematologic cancer	1.38e-05	0.000284	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—IDH2—hematologic cancer	1.38e-05	0.000284	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CSF2—hematologic cancer	1.38e-05	0.000284	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—IL2RA—hematologic cancer	1.36e-05	0.000282	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—XIAP—hematologic cancer	1.36e-05	0.00028	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCG—hematologic cancer	1.33e-05	0.000274	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—JAK1—hematologic cancer	1.33e-05	0.000274	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SH2B3—hematologic cancer	1.32e-05	0.000273	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SMARCA4—hematologic cancer	1.32e-05	0.000273	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GZMB—hematologic cancer	1.31e-05	0.000271	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.3e-05	0.000268	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.3e-05	0.000267	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CTNNA1—hematologic cancer	1.28e-05	0.000265	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EIF4EBP1—hematologic cancer	1.27e-05	0.000263	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HSPB1—hematologic cancer	1.27e-05	0.000263	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL3—hematologic cancer	1.27e-05	0.000263	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTHLH—hematologic cancer	1.26e-05	0.00026	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SDC1—hematologic cancer	1.26e-05	0.00026	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ACP5—hematologic cancer	1.26e-05	0.00026	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CA9—hematologic cancer	1.26e-05	0.00026	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.24e-05	0.000257	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL2RA—hematologic cancer	1.24e-05	0.000256	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTGER4—hematologic cancer	1.23e-05	0.000253	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LCK—hematologic cancer	1.22e-05	0.000252	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—H3F3A—hematologic cancer	1.2e-05	0.000247	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—IDH1—hematologic cancer	1.18e-05	0.000245	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TXN—hematologic cancer	1.17e-05	0.000242	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.17e-05	0.000242	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.17e-05	0.000242	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCZ—hematologic cancer	1.16e-05	0.00024	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.15e-05	0.000237	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	1.14e-05	0.000235	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PARP1—hematologic cancer	1.12e-05	0.000232	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FBXW7—hematologic cancer	1.11e-05	0.000228	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.1e-05	0.000227	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HDAC2—hematologic cancer	1.08e-05	0.000224	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCR4—hematologic cancer	1.08e-05	0.000224	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.07e-05	0.000221	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.07e-05	0.000221	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CBL—hematologic cancer	1.06e-05	0.000218	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL3—hematologic cancer	1.05e-05	0.000216	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.04e-05	0.000216	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	1.03e-05	0.000213	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTPN1—hematologic cancer	1.03e-05	0.000212	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	1.01e-05	0.000209	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NUP98—hematologic cancer	1.01e-05	0.000209	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	1.01e-05	0.000209	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SYK—hematologic cancer	1.01e-05	0.000208	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	1.01e-05	0.000208	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	1e-05	0.000206	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CREB1—hematologic cancer	9.83e-06	0.000203	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADCY7—hematologic cancer	9.82e-06	0.000203	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCOA3—hematologic cancer	9.82e-06	0.000203	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NUP214—hematologic cancer	9.75e-06	0.000201	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT1—hematologic cancer	9.72e-06	0.000201	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.65e-06	0.000199	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL2—hematologic cancer	9.62e-06	0.000199	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6R—hematologic cancer	9.59e-06	0.000198	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTR—hematologic cancer	9.55e-06	0.000197	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCG2—hematologic cancer	9.55e-06	0.000197	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	9.44e-06	0.000195	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ENO2—hematologic cancer	9.37e-06	0.000193	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	9.17e-06	0.000189	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	9.14e-06	0.000189	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GRB2—hematologic cancer	9.09e-06	0.000188	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTT1—hematologic cancer	9.08e-06	0.000188	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	9.08e-06	0.000187	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	9.07e-06	0.000187	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.95e-06	0.000185	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KITLG—hematologic cancer	8.94e-06	0.000185	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SDC1—hematologic cancer	8.88e-06	0.000183	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	8.74e-06	0.00018	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	8.71e-06	0.00018	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	8.66e-06	0.000179	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	8.57e-06	0.000177	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.48e-06	0.000175	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CD86—hematologic cancer	8.38e-06	0.000173	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.37e-06	0.000173	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	8.33e-06	0.000172	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HES1—hematologic cancer	8.26e-06	0.000171	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	8.22e-06	0.00017	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF1—hematologic cancer	8.12e-06	0.000168	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CSF2—hematologic cancer	8.12e-06	0.000168	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.01e-06	0.000165	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	8.01e-06	0.000165	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	8e-06	0.000165	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	7.99e-06	0.000165	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	7.91e-06	0.000163	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	7.87e-06	0.000162	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	7.84e-06	0.000162	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JAK1—hematologic cancer	7.84e-06	0.000162	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NQO1—hematologic cancer	7.55e-06	0.000156	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CD44—hematologic cancer	7.55e-06	0.000156	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.39e-06	0.000153	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	7.32e-06	0.000151	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL2—hematologic cancer	7.27e-06	0.00015	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TERT—hematologic cancer	7.24e-06	0.000149	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYCS—hematologic cancer	7.14e-06	0.000147	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	7.1e-06	0.000147	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	7.07e-06	0.000146	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TSC2—hematologic cancer	6.91e-06	0.000143	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	6.64e-06	0.000137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	6.58e-06	0.000136	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ESR1—hematologic cancer	6.45e-06	0.000133	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.39e-06	0.000132	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FN1—hematologic cancer	6.37e-06	0.000132	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BAD—hematologic cancer	6.3e-06	0.00013	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	6.3e-06	0.00013	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.3e-06	0.00013	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	6.24e-06	0.000129	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CD80—hematologic cancer	6.11e-06	0.000126	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	6.1e-06	0.000126	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KIT—hematologic cancer	6.1e-06	0.000126	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	6.1e-06	0.000126	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.09e-06	0.000126	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	5.99e-06	0.000124	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.96e-06	0.000123	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	5.84e-06	0.000121	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CREB1—hematologic cancer	5.81e-06	0.00012	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.79e-06	0.000119	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.79e-06	0.000119	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BRAF—hematologic cancer	5.73e-06	0.000118	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL2—hematologic cancer	5.68e-06	0.000117	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6R—hematologic cancer	5.66e-06	0.000117	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	5.66e-06	0.000117	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	5.4e-06	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	5.36e-06	0.000111	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.31e-06	0.00011	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	5.25e-06	0.000108	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF2—hematologic cancer	5.13e-06	0.000106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.11e-06	0.000106	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	5.06e-06	0.000105	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JAK2—hematologic cancer	4.92e-06	0.000102	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	4.82e-06	9.96e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MDM2—hematologic cancer	4.8e-06	9.92e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	4.67e-06	9.65e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MTOR—hematologic cancer	4.67e-06	9.65e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.51e-06	9.3e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	4.46e-06	9.21e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	4.39e-06	9.05e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	4.34e-06	8.96e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CASP3—hematologic cancer	4.3e-06	8.87e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.3e-06	8.87e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL2—hematologic cancer	4.29e-06	8.86e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—hematologic cancer	4.27e-06	8.82e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCND1—hematologic cancer	4.18e-06	8.64e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JUN—hematologic cancer	4.18e-06	8.62e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	4.05e-06	8.36e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTEN—hematologic cancer	4.04e-06	8.34e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.98e-06	8.22e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	3.95e-06	8.16e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	3.94e-06	8.13e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EP300—hematologic cancer	3.85e-06	7.95e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.78e-06	7.8e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SRC—hematologic cancer	3.75e-06	7.73e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALB—hematologic cancer	3.73e-06	7.7e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	3.65e-06	7.53e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT3—hematologic cancer	3.61e-06	7.46e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NRAS—hematologic cancer	3.6e-06	7.44e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.57e-06	7.36e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	3.45e-06	7.12e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MYC—hematologic cancer	3.36e-06	6.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	3.35e-06	6.91e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.29e-06	6.8e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KRAS—hematologic cancer	3.1e-06	6.4e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	2.85e-06	5.88e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTEN—hematologic cancer	2.84e-06	5.87e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TP53—hematologic cancer	2.76e-06	5.69e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—EP300—hematologic cancer	2.71e-06	5.6e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HRAS—hematologic cancer	2.64e-06	5.44e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—hematologic cancer	2.52e-06	5.21e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT1—hematologic cancer	2.33e-06	4.8e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.64e-06	3.38e-05	CbGpPWpGaD
